Raoul S. Concepcion, MD, FACS, discusses barriers to genetic testing for patients with prostate cancer as identified by community urologists.
Raoul S. Concepcion, MD, FACS, director, Comprehensive Prostate Center, discusses barriers to genetic testing for patients with prostate cancer as identified by community urologists.
Of the 52 urology practices that participated in an 8-question online survey, 32 are currently offering genetic testing to patients who qualify; however, there are several challenges that providers encounter in clinic.
The number 1 challenge identified by 22% of practices concerns medical or legal liability for results that go unaddressed, explains Concepcion.
Secondly, 20% of practices were apprehensive about patient expenses and reimbursement. This is perhaps a reflection of tissue-based somatic testing expenses, says Concepcion.
Finally, the third most commonly cited concern identified by 18% of practices relates to the difficulty of obtaining a complete family history. Historically, urologists have not had to acquire this information; however, it is vital for genetic testing, concludes Concepcion.